Skip to main content
SpringerLink
Log in

Lymphatisches und retikuloendotheliales Gewebe

  • Chapter
Therapie der Krankheiten des Kindesalters

  • 46 Accesses

Zusammenfassung

Der Morbus Hodgkin (Lymphogranulomatose) scheint in T-Zell-abhängigen Arealen des lymphatischen Gewebes zu entstehen. Die eigentliche Tumorzelle ist die Reed-Sternberg-Zelle, eine Riesenzelle, deren Zuordnung nicht genau bekannt ist. Es wird vermutet, daß es sich hierbei um eine antigenpräsentierende, mononukleäre Phagozytosezelle oder Retikulumzelle handelt. Ursächlich wird ein infektiöses Agens von niedriger Virulenz oder Infektiosität als Krankheitsauslöser diskutiert. Jungen erkranken 2mal so häufig wie Mädchen. Die Erkrankung ist sehr selten vor dem 5. Lebensjahr und nimmt im Kindes- und Jugendalter bis zum 15. Lebensjahr kontinuierlich zu.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bennett MH, MacLennan KA, Easterling MJ, Vaughan Hudson B, Vaugham Hudson G, Jelliffe AM (1985) Analysis of histological subtypes in Hodgkin’s disease in relation to prognosis and survival. In: Quaglino D, Hayhoe FGJ (eds) The cytobiology of leukaemias and lymphomas. Serono symposia publications, vol 20. Raven, New York, p 15.

    Google Scholar 

  2. Blayney DW, Longo DL, Young RC Greene MH, Hubbard SM, Postal MG Duffey PL, De Vita VT Jr (1987) Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin’s disease. N Engl J Med 316:710–714.

    Article  PubMed  CAS  Google Scholar 

  3. Brämswig JH, Heimes U, Heiermann E, Schlegel W, Nieschlag E, Schellong G (1990) The effect of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin’s disease during childhood or adolescence. Cancer 65:1298–1302.

    Article  PubMed  Google Scholar 

  4. Donaldson SS (1991) Making choices in the staging of children with Hodgkin’s disease. Med Pediat Oncol 19:211–213.

    Article  CAS  Google Scholar 

  5. Garden AS, Woo SY, Fuller LM, Sullivan MP Ramirez I (1991) Results of changing treatment philosophy for children with stage I Hodgkin’s disease: a 35-year experience. Med Pediat Oncol 19:214–220.

    Article  CAS  Google Scholar 

  6. Meadows AT, Obringer AC, Lansberg P, Marrero O, Lemerle J (1989) Second malignant neoplasms following childhood Hodgkin’s disease: treatment and splenectomy as risk factors. Med Pediat Oncol 17: 477–484.

    Article  CAS  Google Scholar 

  7. Schellong G, Brämswig JH, Schwarze EW, Wannenmacher M (1988) An approach to reduce treatment. and invasive staging in childhood Hodgkin’s disease: the sequence of the German DAL multicenter studies. Bull Cancer 75:41–51.

    PubMed  CAS  Google Scholar 

  8. Schellong G, Hörnig I, Brämswig JH et al. (1988) Zur Bedeutung des Procarbazins in der Chemotherapie des Morbus Hodgkin — ein Bericht der Kooperativen Therapiestudie DAL-HD-85. Klin Pädiat 200: 205–213.

    Article  CAS  Google Scholar 

  9. Schellong G, Lietzke S, Strauch S, Kühne B, Schneider B (1986) Bedeutung sonographischer, computertumograpischer und klinischer Befunde für die Erkennung eines Abdominalbefalls beim Morbus Hodgkin im Kindesalter — eine retrospektive statistische Analyse bei 145 Patienten der Therapiestudie DAL-HD-82. Klin Pädiat 198:147–154.

    Article  CAS  Google Scholar 

  10. Deeg HG, Torrisi J, Cottler-Fox M, Urban C, Gadner H, Spitzer TR (1989) Escalating doses of VP16 with cyclophosphamide and fractionated total body irradiation or busulfan as conditioning for bone marrow transplantation. Bone Marrow Transplat 4 (Suppl 2):76.

    Google Scholar 

  11. Lennert K, Feller AC (1990) Histopathologie der Non-Hodgkin-Lymphome nach der aktualisierten Kiel-Klassifikation. Mit einem klinisch-therapeutischen Beitrag von M. Engelhard und G. Brittinger. Springer, Berlin Heidelberg New York.

    Google Scholar 

  12. Link MP, Donaldson SS, Berard CW, Shuster JJ, Murphy SB (1990) Results of treatment of childhood localized Non-Hodgkin’s lymphoma with combination chemotherapy with or without radiotherapy. N Engl J Med 322:1169–1174.

    Article  PubMed  CAS  Google Scholar 

  13. Müller-Weihrich S, Henze G, Jobke A et al (1982) BFM-Studie 1975/81 zur Behandlung der Non-Hodgkin-Lymphome hoher Malignität bei Kindern und Jugendlichen. Klin Pädiat 194:219–225.

    Article  Google Scholar 

  14. Murphy SB (1980) Classification, staging and results of treatment in childhood Non-Hodgkins lymphoma: dissimilarities from lymphomas in adults. Semin Oncol 7:332–339.

    PubMed  CAS  Google Scholar 

  15. Riehm H, Gadner J, Henze G et al (1990) Results and significance of six randomized trials in four consecutive ALL-BFM studies. In: Büchner T, Schellong G, Hiddemann W, Ritter J (eds) Haematology and blood transfusion, vol 33: Acute leukemias II. Springer, Berlin Heidelberg New York, pp 439–449.

    Chapter  Google Scholar 

  16. Stapleton FB, Strother DR, Roy S (1988) Acute renal failure at onset of therapy for advanced stage Burkittlymphoma and B-cell acute lymphoblastic lymphoma. Pediatrics 82:863–869.

    PubMed  CAS  Google Scholar 

  17. Broadbent V, Pritchard J, Yeomans E (1989) Etoposide (VP-16) in the treatment of multisystemic Langerhans Cell Histocytosis (Histiocytosis X). Med Pediat Oncol 17:97–100.

    Article  CAS  Google Scholar 

  18. Broadbent V, McLelland J, Yeomans E, Pritchard J (1989) Results of conservative treatment in patients with LCH. Arch Dis Child 17:244–256.

    Google Scholar 

  19. Gadner H, Beck HD, Janka GE, Kühl J (1985) Histiocytosis: diagnosis and treatment. Monogr Paediat 18:1–19.

    Google Scholar 

  20. Gadner H, Heitger A, Ritter J et al (1987) Langerhans-Zell-Histiozytose im Kindesalter — Ergebnisse der DAI-HX 83 Studie. Klin Pädiat 199:173–182.

    Article  CAS  Google Scholar 

  21. Lichtenstein L (1953) Histiocytosis X: Integration of eosinophilic granuloma of bone, „Letterer-Siwe“ and „Schüller-Christian“ disease as related manifestations of a single nosologic entity. Arch Pathol 56:84–102.

    CAS  Google Scholar 

  22. Buckley P, Eisen R, Foucar E, Rosai J, Dorfman R (1991) Sinus histiocytosis with massive lymphadenopathy (SHML): a disease of activated macrophages? Med Pediat Oncol 19:516 (Abstr).

    Google Scholar 

  23. Carstensen H, Oernvold K, Georgsen J, Hansen M, Ralfkiaer E (1991) Clinicopathologic and immunologic findings in two siblings with familial hemophagocytic lymphohistiocytosis. Med Pediat Oncol 19:512 (Abstr).

    Google Scholar 

  24. Elinder G, Henter JI, Söder O, Üst A (1991) Isolated CNS disease; another face of familiar hemophagocytic lymphohistiocytosis (FHL). Med Pediat Oncol 19:514 (Abstr).

    Google Scholar 

  25. Heitger A, Bucsky P, Feller A, Riehm HJ, Gadner H (1991) Clinical similarities of large cell anaplastic lymphoma and malignant histiocytosis. Med Pediat Oncol 19:517 (Abstr).

    Google Scholar 

  26. Henter J, Elenden G (1991) Familial hemophagocytic lymphohistiocytosis. Acta Paediat 80:269–277.

    Article  CAS  Google Scholar 

  27. Komp D, Rosai J (1991) Treatment of histiocytosis with massive lymphadenopathy (SHML). Med Pediat Oncol 19:517 (Abstr).

    Google Scholar 

  28. Writing Group of the Histiocyte Society (1987) Histiocytosis syndromes in childhood. Lancet I:208–209.

    Google Scholar 

  29. Kendig EL, Brummer DL (1976) Prognosis of sarkoidosis in children. Chest 70:351.

    Article  PubMed  CAS  Google Scholar 

  30. Pattishall EN, Strope GL, Spinola SM, Denny FW (1986) Childhood sarkoidosis. J Pediat 108:169–177.

    Article  PubMed  CAS  Google Scholar 

  31. Wurm K (1987) Sarkoidose-Therapie, Theorie und Praxis. Med Welt 38:1649–1653.

    Google Scholar 

  32. Ziesche R, Matthys H (1990) Immunologische Systemerkrankungen der Lunge unbekannter Genese. Internist 31:61–68.

    PubMed  CAS  Google Scholar 

  33. Eraklis AJ, Riller RM (1972) Splenektomy in childhood: a review of 1413 cases. J Pediat Surg 7:382–388.

    Article  PubMed  CAS  Google Scholar 

  34. Likhite VV (1976) Immunological impairment and susceptibility to infection after splenectomy. JAMA 236:1376.

    Article  PubMed  CAS  Google Scholar 

  35. Pearson HA (1980) Splenectomy, its risk and role. Hosp Pract 94:85.

    Google Scholar 

  36. Hilliard RI, McKendry MJ (1990) Congenital abnormalities of the lymphphatic system: A new clinical classification. Pediatrics 86:988.

    PubMed  CAS  Google Scholar 

  37. Fornasiero A, Daniele O, Ghiotto C et al (1990) Chemotherapy of invasive thymoma. J Clin Oncol 8: 1419–1423.

    PubMed  CAS  Google Scholar 

  38. Watts RG, Kelly DR (1990) Fatal varicella infection in a child associated with thymoma and immunodeficiency (Good’s syndrome). Med Pediat Oncol 18: 246–251.

    Article  CAS  Google Scholar 

Download references

Authors
  1. U. Göbel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Reinhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Kinderpoliklinik, Ludwig-Maximilians-Universität, Pettenkoferstraße 8a, D-80336, München, Deutschland

    Dietrich Reinhardt (Direktor) (Direktor)

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Göbel, U., Reinhardt, D. (1994). Lymphatisches und retikuloendotheliales Gewebe. In: Reinhardt, D. (eds) Therapie der Krankheiten des Kindesalters. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-22535-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-22535-6_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-22536-3

  • Online ISBN: 978-3-662-22535-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation